speb/financial-data huggingface dataset:
Financial ratios for 2692.HK — quarterly report dated 2024-12-31
Total revenue: 63991813.26027398
Gross profit: 19927300.415068492
Operating income: 8165276.024657534
Net income: 9031454.889041096
Capital expenditures: 6007596.173972603
Net tangible assets: 435324704.01095897
Owner earnings: 3023858.715068493
Return on net tangible assets (%): 0.6946214371037325
Capex to operating income (%): 73.574930667755
Buffett classification: The Good
Shares outstanding: 26748300
Book value: 441946679.43424654
Debt to equity: 0.04730099358919414
Current ratio: 3.6615772303947725
Quick ratio: 3.4322162101129288
Effective tax rate (%): 9.26118973267942
Interest coverage ratio: 491.27881707056747
COGS to revenue (%): 68.85960969098005
R&D to revenue (%): 10.006064459399614
SG&A to revenue (%): -8.791619163729465
Free cash flow (dilution-adjusted): -10819126.106849315
Retained earnings: 143456270.81369865
Inventory turnover: 1.7470370686248378
Receivables turnover: 0.8534203270095508
Capitalized R&D asset: 6403062.083561644
ROCI (R&D-adjusted, %): 2.6967081593688977
FCF margin (%): -16.90704725438029
Rule of 40 score: -16.90704725438029
Financial ratios for 2692.HK — annual report dated 2024-12-31
Total revenue: 208849116.9041096
Gross profit: 65632509.94931507
Operating income: 26291829.915068492
Net income: 30834841.75890411
Capital expenditures: 23059931.038356166
Operating cash flow: 16942776.802739725
Depreciation & amortization: 10620552.483561644
Net tangible assets: 435324704.01095897
Owner earnings: 18395463.20410959
Return on net tangible assets (%): 4.225687868071576
Capex to operating income (%): 87.70759248347318
Buffett classification: The Gruesome
Shares outstanding: 26748300
Book value: 441946679.43424654
Debt to equity: 0.04730099358919414
Current ratio: 3.6615772303947725
Quick ratio: 3.4322162101129288
Effective tax rate (%): 7.896019242597332
Interest coverage ratio: 79.61165049808208
COGS to revenue (%): 68.57419800369594
R&D to revenue (%): 10.175523818649323
SG&A to revenue (%): 2.357244158460842
Free cash flow (dilution-adjusted): -6159245.742465754
Retained earnings: 143456270.81369865
Inventory turnover: 5.67814563323656
Receivables turnover: 2.7852950645267907
Capitalized R&D asset: 38944239.07879931
ROCI (R&D-adjusted, %): 5.835504488152705
Rosenberg metric: 0.910115198687594
FCF margin (%): -2.9491365985970117
Revenue growth (%): 23.133045544731278
Rule of 40 score: 20.183908946134267
Financial ratios for 2692.HK — quarterly report dated 2025-03-31
Total revenue: 50624027.25206612
Gross profit: 16041937.03168044
Operating income: 6478419.960055096
Net income: 7535800.953168045
Capital expenditures: 5673849.110192837
Net tangible assets: 447085254.26859504
Owner earnings: 1861951.8429752076
Return on net tangible assets (%): 0.4164646060674156
Capex to operating income (%): 87.58075495532684
Buffett classification: The Gruesome
Shares outstanding: 26748300
Book value: 453612259.55785125
Debt to equity: 0.07440466487511892
Current ratio: 3.579644317629206
Quick ratio: 3.3466711789641934
Effective tax rate (%): 9.793459481063117
Interest coverage ratio: 42.72291723624254
COGS to revenue (%): 68.31161426212743
R&D to revenue (%): 10.792233541807589
SG&A to revenue (%): 9.980006889924587
Free cash flow (dilution-adjusted): -4696511.136363637
Retained earnings: 151241703.15013772
Inventory turnover: 1.2830449511872741
Receivables turnover: 0.796461060740883
Capitalized R&D asset: 9753514.845297597
ROCI (R&D-adjusted, %): 1.6833279327476063
Rosenberg metric: -0.6067977059542822
FCF margin (%): -9.277237294810357
Revenue growth (%): -20.889837820092776
Rule of 40 score: -30.167075114903135
Financial ratios for 2692.HK — quarterly report dated 2025-06-30
Total revenue: 58443272.39051604
Gross profit: 18824663.53417015
Operating income: 6556989.422594142
Net income: 8167538.075313807
Capital expenditures: 7236585.383542539
Net tangible assets: 452123391.8940028
Owner earnings: 930952.6917712688
Return on net tangible assets (%): 0.20590677422625464
Capex to operating income (%): 110.36445107882342
Buffett classification: The Gruesome
Shares outstanding: 26748300
Book value: 458638399.5718271
Debt to equity: 0.04948579587219713
Current ratio: 3.5876804806469793
Quick ratio: 3.3227462462296264
Effective tax rate (%): 8.932048141298463
Interest coverage ratio: 86.45437492628223
COGS to revenue (%): 67.78985370910723
R&D to revenue (%): 9.959962230469634
SG&A to revenue (%): -3.7389965265545215
Free cash flow (dilution-adjusted): -1713948.3026499304
Retained earnings: 149773825.23570433
Inventory turnover: 1.316154800415034
Receivables turnover: 0.8371150721631541
Capitalized R&D asset: 11594458.720959796
ROCI (R&D-adjusted, %): 1.3470556951394652
Rosenberg metric: 0.5093338008342037
FCF margin (%): -2.932669976447218
Revenue growth (%): 15.445719281708856
Rule of 40 score: 12.513049305261639
Financial ratios for 2692.HK — quarterly report dated 2025-12-31
Total revenue: 65763681.08714286
Gross profit: 24675857.441428572
Operating income: 10761642.16857143
Net income: 10437801.475714285
Capital expenditures: 6656519.132857143
Net tangible assets: 490863605.50428575
Owner earnings: 3781282.342857142
Return on net tangible assets (%): 0.7703325935057794
Capex to operating income (%): 61.85412066847018
Buffett classification: The Good
Shares outstanding: 26748300
Book value: 497570704.4228571
Debt to equity: 0.05079472063177452
Current ratio: 4.073753756467762
Quick ratio: 3.7932162104786706
Effective tax rate (%): 5.516194951559096
Interest coverage ratio: 1952.376113011125
COGS to revenue (%): 62.477986278275964
R&D to revenue (%): 10.076916175603893
SG&A to revenue (%): -11.097736680677201
Free cash flow (dilution-adjusted): 1501005.332857143
Retained earnings: 173375302.72714284
Inventory turnover: 1.3677973325346902
Receivables turnover: 0.8852461315677275
Capitalized R&D asset: 12329915.553167328
ROCI (R&D-adjusted, %): 2.1870529061953192
Rosenberg metric: 1.0051995234539008
FCF margin (%): 2.282422924088106
Revenue growth (%): 12.525665311333162
Rule of 40 score: 14.808088235421268
Financial ratios for 2692.HK — annual report dated 2025-12-31
Total revenue: 245076332.80428573
Gross profit: 82482507.26571429
Operating income: 33089314.728571426
Net income: 36327459.66142857
Capital expenditures: 24339452.497142855
Operating cash flow: 22773221.332857143
Depreciation & amortization: 14072102.862857144
Net tangible assets: 490863605.50428575
Owner earnings: 26060110.027142864
Return on net tangible assets (%): 5.3090328423045685
Capex to operating income (%): 73.55683457574483
Buffett classification: The Good
Shares outstanding: 26748300
Book value: 497570704.4228571
Debt to equity: 0.05079472063177452
Current ratio: 4.073753756467762
Quick ratio: 3.7932162104786706
Effective tax rate (%): 7.760296995153411
Interest coverage ratio: 91.31414903032422
COGS to revenue (%): 66.34415640143285
R&D to revenue (%): 10.16027905705583
SG&A to revenue (%): 2.321903050380288
Free cash flow (dilution-adjusted): -1587473.45
Retained earnings: 173375302.72714284
Inventory turnover: 5.412683883573521
Receivables turnover: 3.2989770640471994
Capitalized R&D asset: 45112995.60782203
ROCI (R&D-adjusted, %): 6.591074040976667
Rosenberg metric: 0.7928853938967494
FCF margin (%): -0.6477465334311707
Revenue growth (%): 17.3461187852709
Rule of 40 score: 16.69837225183973
Financial ratios for 365A.T — annual report dated 2024-02-29
Total revenue: 65968518.51851852
Gross profit: 15191298.287534848
Operating income: 6435530.333200584
Net income: 7321578.388424267
Capital expenditures: 9617.68219832736
Operating cash flow: 9441245.18784017
Depreciation & amortization: 1414217.4432497013
Net tangible assets: 2831634.1431036773
Owner earnings: 8726178.149475642
Return on net tangible assets (%): 308.1675706845064
Capex to operating income (%): 0.1494466143483189
Buffett classification: The Great
Shares outstanding: 9100000
Book value: 26258144.16567105
Debt to equity: 0.8910398548856283
Current ratio: 2.456729683811733
Quick ratio: 2.30936955472732
Effective tax rate (%): 37.74567873503635
Interest coverage ratio: 28.614596859874865
COGS to revenue (%): 76.9718870968245
Free cash flow (dilution-adjusted): 9428036.638789328
Retained earnings: 8080100.889419886
Inventory turnover: 28.24226393083131
Receivables turnover: 6.22790256997355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.371533762061869
FCF margin (%): 14.291721036819574
Rule of 40 score: 14.291721036819574
Financial ratios for 365A.T — annual report dated 2025-02-28
Total revenue: 65498033.46443571
Gross profit: 13561175.921605228
Operating income: 4253963.069128725
Net income: 3856629.558029465
Capital expenditures: 27544.83034464369
Operating cash flow: 4291607.226184921
Depreciation & amortization: 1416432.23785081
Net tangible assets: 3700493.300446637
Owner earnings: 5245516.965535631
Return on net tangible assets (%): 141.75182981421733
Capex to operating income (%): 0.647509860735234
Buffett classification: The Great
Shares outstanding: 9100000
Book value: 25880081.32791147
Debt to equity: 0.8487300345596689
Current ratio: 2.927669152466665
Quick ratio: 2.635105963477235
Effective tax rate (%): 40.97073708268712
Interest coverage ratio: 23.46695840841393
COGS to revenue (%): 79.2952828191537
Free cash flow (dilution-adjusted): 4264062.395840278
Retained earnings: 7623338.444103727
Inventory turnover: 18.586133601790138
Receivables turnover: 6.510348922038364
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.18543410786768
FCF margin (%): 6.510214384002215
Revenue growth (%): -0.7131963315967713
Rule of 40 score: 5.797018052405444
Financial ratios for BCO.DE — annual report dated 2022-12-31
Total revenue: 66608000000
Gross profit: 3530000000
Operating income: -3509000000
Net income: -4935000000
Capital expenditures: 1187000000
Operating cash flow: 3512000000
Depreciation & amortization: 1979000000
Net tangible assets: -26251000000
Owner earnings: -4143000000
Buffett classification: The Gruesome
Shares outstanding: 788302331
Book value: -15848000000
Debt to equity: -3.6141468955073197
Current ratio: 1.2162195176120463
Quick ratio: 0.34837649358148626
Interest coverage ratio: -1.370167903162827
COGS to revenue (%): 94.70033629594042
R&D to revenue (%): 4.281767955801105
SG&A to revenue (%): 6.286031707902954
Free cash flow (dilution-adjusted): 1565000000
Retained earnings: 29473000000
Inventory turnover: 0.8071297872068176
Receivables turnover: 5.891906236178682
Capitalized R&D asset: 2852000000
ROCI (R&D-adjusted, %): -3.2217768871075485
FCF margin (%): 2.3495676195051645
Rule of 40 score: 2.3495676195051645
Financial ratios for BCO.DE — annual report dated 2023-12-31
Total revenue: 77794000000
Gross profit: 7724000000
Operating income: -821000000
Net income: -2222000000
Capital expenditures: 1500000000
Operating cash flow: 5960000000
Depreciation & amortization: 1861000000
Net tangible assets: -27420000000
Owner earnings: -1861000000
Buffett classification: The Gruesome
Shares outstanding: 788302331
Book value: -17228000000
Debt to equity: -3.053343394474112
Current ratio: 1.14033623091613
Quick ratio: 0.30820123764700974
Interest coverage ratio: -0.33387555917039446
COGS to revenue (%): 90.07121371828161
R&D to revenue (%): 4.3409517443504635
SG&A to revenue (%): 6.643185849808468
Free cash flow (dilution-adjusted): 3743000000
Retained earnings: 27251000000
Inventory turnover: 0.8787198555322858
Receivables turnover: 7.030637144148215
Capitalized R&D asset: 5287840000
ROCI (R&D-adjusted, %): 1.0321440795670478
Rosenberg metric: 1.47054698457223
FCF margin (%): 4.81142504563334
Revenue growth (%): 16.79377852510209
Rule of 40 score: 21.60520357073543
Financial ratios for BCO.DE — annual report dated 2024-12-31
Total revenue: 66517000000
Gross profit: -1991000000
Operating income: -10824000000
Net income: -11817000000
Capital expenditures: 2181000000
Operating cash flow: -12080000000
Depreciation & amortization: 1836000000
Net tangible assets: -13949000000
Owner earnings: -12162000000
Buffett classification: The Gruesome
Shares outstanding: 788302331
Book value: -3914000000
Debt to equity: -13.844660194174757
Current ratio: 1.318506767753765
Quick ratio: 0.4166546488390779
Interest coverage ratio: -3.972110091743119
COGS to revenue (%): 102.99321977840252
R&D to revenue (%): 5.730865793706872
SG&A to revenue (%): 7.548446261857871
Free cash flow (dilution-adjusted): -14805000000
Retained earnings: 15362000000
Inventory turnover: 0.7825014277555683
Receivables turnover: 5.938487635032587
Capitalized R&D asset: 7015750000
ROCI (R&D-adjusted, %): -15.624257644144295
Rosenberg metric: -2.8768137400059226
FCF margin (%): -22.25746801569524
Revenue growth (%): -14.495976553461706
Rule of 40 score: -36.75344456915694
Financial ratios for BCO.DE — quarterly report dated 2025-03-31
Total revenue: 19496000000
Gross profit: 2417000000
Operating income: 461000000
Net income: -31000000
Capital expenditures: 671000000
Operating cash flow: -1616000000
Depreciation & amortization: 466000000
Net tangible assets: -13320000000
Owner earnings: -236000000
Capex to operating income (%): 145.55314533622558
Buffett classification: The Gruesome
Shares outstanding: 788302331
Book value: -3325000000
Debt to equity: -16.125714285714285
Current ratio: 1.2316167248731356
Quick ratio: 0.3722480560325699
Effective tax rate (%): 140.78947368421052
Interest coverage ratio: 0.6511299435028248
COGS to revenue (%): 87.60258514567091
R&D to revenue (%): 4.329093147312269
SG&A to revenue (%): 5.703734099302421
Free cash flow (dilution-adjusted): -2425000000
Retained earnings: 15239000000
Inventory turnover: 0.19173299504922708
Receivables turnover: 1.5675806062555278
Capitalized R&D asset: 844000000
ROCI (R&D-adjusted, %): 1.906837543153764
FCF margin (%): -12.438448912597456
Rule of 40 score: -12.438448912597456
Financial ratios for BCO.DE — quarterly report dated 2025-06-30
Total revenue: 22749000000
Gross profit: 2435000000
Operating income: -268000000
Net income: -611000000
Capital expenditures: 426000000
Operating cash flow: 227000000
Depreciation & amortization: 460000000
Net tangible assets: -12117000000
Owner earnings: -577000000
Buffett classification: The Gruesome
Shares outstanding: 788302331
Book value: -3296000000
Debt to equity: -16.178094660194176
Current ratio: 1.2314366971057111
Quick ratio: 0.38159727596347315
Interest coverage ratio: -0.37746478873239436
COGS to revenue (%): 89.29623280144182
R&D to revenue (%): 4.0001758319046985
SG&A to revenue (%): 7.8816651281375005
Free cash flow (dilution-adjusted): -319000000
Retained earnings: 14542000000
Inventory turnover: 0.23122716355730596
Receivables turnover: 1.8247373064891312
Capitalized R&D asset: 1475480000
ROCI (R&D-adjusted, %): 0.1077299765674775
Rosenberg metric: 0.02132701421800948
FCF margin (%): -1.4022594399753836
Revenue growth (%): 16.685473943373
Rule of 40 score: 15.283214503397618
Financial ratios for BCO.DE — quarterly report dated 2025-09-30
Total revenue: 23270000000
Gross profit: -2375000000
Operating income: -4794000000
Net income: -5337000000
Capital expenditures: 884000000
Operating cash flow: 1123000000
Depreciation & amortization: 491000000
Net tangible assets: -17026000000
Owner earnings: -5730000000
Buffett classification: The Gruesome
Shares outstanding: 788302331
Book value: -8253000000
Debt to equity: -6.464679510481037
Current ratio: 1.1820293445859626
Quick ratio: 0.3842960009291162
Interest coverage ratio: -6.9077809798270895
COGS to revenue (%): 110.20627417275462
R&D to revenue (%): 3.8547486033519553
SG&A to revenue (%): 6.540610227761066
Free cash flow (dilution-adjusted): 149000000
Retained earnings: 9118000000
Inventory turnover: 0.31113133151349714
Receivables turnover: 1.884820994654139
Capitalized R&D asset: 1785220000
ROCI (R&D-adjusted, %): -9.860252813527095
Rosenberg metric: -5.285714285714286
FCF margin (%): 0.6403094112591319
Revenue growth (%): 2.290210558705877
Rule of 40 score: 2.930519969965009
Financial ratios for BCO.DE — annual report dated 2025-12-31
Total revenue: 89463000000
Gross profit: 4289000000
Operating income: -5416000000
Net income: 2238000000
Capital expenditures: 2860000000
Operating cash flow: 1065000000
Depreciation & amortization: 1953000000
Net tangible assets: -13388000000
Owner earnings: 1331000000
Return on net tangible assets (%): -9.941738870630415
Buffett classification: The Gruesome
Shares outstanding: 788302331
Book value: 5457000000
Debt to equity: 9.974894630749496
Current ratio: 1.1881700041622347
Quick ratio: 0.40493918512694815
Effective tax rate (%): 15.06641366223909
Interest coverage ratio: -1.9545290508841573
COGS to revenue (%): 95.20583928551468
R&D to revenue (%): 4.040776633915697
SG&A to revenue (%): 6.8072834579658625
Free cash flow (dilution-adjusted): -2312000000
Retained earnings: 17252000000
Inventory turnover: 1.0058456051677511
Receivables turnover: 7.406490603526782
Capitalized R&D asset: 7283450000
ROCI (R&D-adjusted, %): -8.014921095779718
Rosenberg metric: 1.6474291710388247
FCF margin (%): -2.5843085968500943
Revenue growth (%): 34.496444517942784
Rule of 40 score: 31.91213592109269
Financial ratios for BCO.DE — quarterly report dated 2025-12-31
Total revenue: 23948000000
Gross profit: 1812000000
Operating income: -815000000
Net income: 8220000000
Capital expenditures: 879000000
Operating cash flow: 1331000000
Depreciation & amortization: 536000000
Net tangible assets: -13388000000
Owner earnings: 7877000000
Return on net tangible assets (%): -58.83627128772034
Buffett classification: The Gruesome
Shares outstanding: 788302331
Book value: 5457000000
Debt to equity: 9.974894630749496
Current ratio: 1.1881700041622347
Quick ratio: 0.40493918512694815
Effective tax rate (%): 1.1900468806346918
Interest coverage ratio: -1.236722306525038
COGS to revenue (%): 92.43360614665109
R&D to revenue (%): 4.025388341406381
SG&A to revenue (%): 6.944212460330716
Free cash flow (dilution-adjusted): 283000000
Retained earnings: 17252000000
Inventory turnover: 0.2614107393804839
Receivables turnover: 1.9826144548389768
Capitalized R&D asset: 1865290000
ROCI (R&D-adjusted, %): -1.2497588809646072
Rosenberg metric: 4.667781493868451
FCF margin (%): 1.1817270753298814
Revenue growth (%): 2.913622690159003
Rule of 40 score: 4.095349765488884
Financial ratios for CWAN — annual report dated 2022-12-31
Total revenue: 303426000
Gross profit: 215642000
Operating income: 5117000
Net income: -6695000
Capital expenditures: 7758000
Operating cash flow: 58005000
Depreciation & amortization: 5139000
Net tangible assets: 196274000
Owner earnings: -9314000
Return on net tangible assets (%): -4.745406931126894
Capex to operating income (%): 151.6122728161032
Buffett classification: The Gruesome
Shares outstanding: 297375155
Book value: 338386000
Debt to equity: 0.22636279278693563
Current ratio: 5.398200327213234
Quick ratio: 5.398200327213234
COGS to revenue (%): 28.930941975967784
R&D to revenue (%): 31.019095265402434
SG&A to revenue (%): 38.363554870050685
Free cash flow (dilution-adjusted): -15444000
Retained earnings: -186647000
Receivables turnover: 3.8294440588123937
Capitalized R&D asset: 94120000
ROCI (R&D-adjusted, %): 13.305296866320296
FCF margin (%): -5.089873642996975
Rule of 40 score: -5.089873642996975
Financial ratios for CWAN — annual report dated 2023-12-31
Total revenue: 368168000
Gross profit: 261041000
Operating income: -16745000
Net income: -21627000
Capital expenditures: 5624000
Operating cash flow: 84602000
Depreciation & amortization: 9929000
Net tangible assets: 282858000
Owner earnings: -17322000
Return on net tangible assets (%): -6.123920836603525
Buffett classification: The Gruesome
Shares outstanding: 297375155
Book value: 409657000
Debt to equity: 0.17594475378182237
Current ratio: 5.148975146054065
Quick ratio: 5.148975146054065
Interest coverage ratio: -3.5409177415944173
COGS to revenue (%): 29.09731426957259
R&D to revenue (%): 33.65990526064188
SG&A to revenue (%): 41.79097585884705
Free cash flow (dilution-adjusted): -25469000
Retained earnings: -181331000
Receivables turnover: 3.647502897847172
Capitalized R&D asset: 186985400
ROCI (R&D-adjusted, %): 5.18821549449441
Rosenberg metric: 0.4823523161920952
FCF margin (%): -6.917765802568393
Revenue growth (%): 21.33699814781858
Rule of 40 score: 14.419232345250187
Financial ratios for CWAN — annual report dated 2024-12-31
Total revenue: 451803000
Gross profit: 328816000
Operating income: 12234000
Net income: 427585000
Capital expenditures: 5259000
Operating cash flow: 74321000
Depreciation & amortization: 12181000
Net tangible assets: 906416000
Owner earnings: 434507000
Return on net tangible assets (%): 47.93681929709979
Capex to operating income (%): 42.98675821481118
Buffett classification: The Good
Shares outstanding: 297375155
Book value: 1030231000
Debt to equity: 0.06980861573763554
Current ratio: 4.992031355448269
Quick ratio: 4.992031355448269
Interest coverage ratio: 2.828670520231214
COGS to revenue (%): 27.221377458759683
R&D to revenue (%): 33.32381591091693
SG&A to revenue (%): 36.74698928515304
Free cash flow (dilution-adjusted): -34139000
Retained earnings: 283946000
Receivables turnover: 4.100887702864612
Capitalized R&D asset: 264647350
ROCI (R&D-adjusted, %): 2.941739891792514
Rosenberg metric: 0.5469033689731693
FCF margin (%): -7.556169392412179
Revenue growth (%): 22.716531583407576
Rule of 40 score: 15.160362190995397
Financial ratios for CWAN — quarterly report dated 2025-03-31
Total revenue: 126864000
Gross profit: 92940000
Operating income: 7082000
Net income: 6936000
Capital expenditures: 1468000
Operating cash flow: 24500000
Depreciation & amortization: 3146000
Net tangible assets: 900334000
Owner earnings: 8614000
Return on net tangible assets (%): 0.9567560483109602
Capex to operating income (%): 20.728607737927142
Buffett classification: The Great
Shares outstanding: 297375155
Book value: 1142607000
Debt to equity: 0.060869572827752676
Current ratio: 5.088100203734735
Quick ratio: 5.088100203734735
Effective tax rate (%): 18.26537827009192
Interest coverage ratio: 7.70620239390642
COGS to revenue (%): 26.740446462353383
R&D to revenue (%): 29.480388447471306
SG&A to revenue (%): 38.19680918148568
Free cash flow (dilution-adjusted): -680000
Retained earnings: 286208000
Receivables turnover: 1.1080696299272432
Capitalized R&D asset: 37400000
ROCI (R&D-adjusted, %): 2.582358623756592
FCF margin (%): -0.5360070626812965
Rule of 40 score: -0.5360070626812965
Financial ratios for CWAN — quarterly report dated 2025-06-30
Total revenue: 181937000
Gross profit: 118514000
Operating income: -14580000
Net income: -23225000
Capital expenditures: 2987000
Operating cash flow: 47081000
Depreciation & amortization: 23606000
Net tangible assets: -40216000
Owner earnings: -2606000
Buffett classification: The Gruesome
Shares outstanding: 297375155
Book value: 1987970000
Debt to equity: 0.46523337877332155
Current ratio: 2.017954924678621
Quick ratio: 2.017954924678621
Interest coverage ratio: -1.0828877005347595
COGS to revenue (%): 34.859869075559125
R&D to revenue (%): 27.347378488157986
SG&A to revenue (%): 45.80651544215855
Free cash flow (dilution-adjusted): 6362000
Retained earnings: 270689000
Receivables turnover: 1.1835302229970597
Capitalized R&D asset: 74813000
ROCI (R&D-adjusted, %): 0.2062851503102306
Rosenberg metric: 0.6837967914438503
FCF margin (%): 3.4968148315076095
Revenue growth (%): 43.41105435742212
Rule of 40 score: 46.90786918892972
Financial ratios for CWAN — quarterly report dated 2025-09-30
Total revenue: 205110000
Gross profit: 134472000
Operating income: 6554000
Net income: -10335000
Capital expenditures: 4057000
Operating cash flow: 48984000
Depreciation & amortization: 29300000
Net tangible assets: 324000
Owner earnings: 14908000
Capex to operating income (%): 61.90112908147696
Buffett classification: The Good
Shares outstanding: 297375155
Book value: 2001551000
Debt to equity: 0.44108493863009235
Current ratio: 1.965364573130118
Quick ratio: 1.965364573130118
Interest coverage ratio: 0.4066009057633848
COGS to revenue (%): 34.439081468480325
R&D to revenue (%): 25.38394032470382
SG&A to revenue (%): 36.98161961874116
Free cash flow (dilution-adjusted): 11402000
Retained earnings: 261009000
Receivables turnover: 1.308141203482254
Capitalized R&D asset: 97742850
ROCI (R&D-adjusted, %): 0.4124896627779071
Rosenberg metric: 0.32073158476535024
FCF margin (%): 5.5589683584418115
Revenue growth (%): 12.736826483892777
Rule of 40 score: 18.295794842334587
Financial ratios for CWAN — annual report dated 2025-12-31
Total revenue: 731368000
Gross profit: 492148000
Operating income: -7686000
Net income: -38807000
Capital expenditures: 11554000
Operating cash flow: 175896000
Depreciation & amortization: 85541000
Net tangible assets: 64098000
Owner earnings: 35180000
Buffett classification: The Gruesome
Shares outstanding: 297375155
Book value: 2031092000
Debt to equity: 0.4235829790083364
Current ratio: 1.83193568980371
Quick ratio: 1.83193568980371
Interest coverage ratio: -0.16831639803784162
COGS to revenue (%): 32.70856805329191
R&D to revenue (%): 26.83026875663141
SG&A to revenue (%): 41.51207053084083
Free cash flow (dilution-adjusted): 26207000
Retained earnings: 259963000
Receivables turnover: 4.253771796154338
Capitalized R&D asset: 337997110
ROCI (R&D-adjusted, %): 0.9860531034626477
Rosenberg metric: 1.0848443789104532
FCF margin (%): 3.583285022040888
Revenue growth (%): 61.877632507973615
Rule of 40 score: 65.4609175300145
Financial ratios for CWAN — quarterly report dated 2025-12-31
Total revenue: 217457000
Gross profit: 146221000
Operating income: -6743000
Net income: -12066000
Capital expenditures: 3042000
Operating cash flow: 55331000
Depreciation & amortization: 29489000
Net tangible assets: 64098000
Owner earnings: 14381000
Buffett classification: The Gruesome
Shares outstanding: 297375155
Book value: 2031092000
Debt to equity: 0.4235829790083364
Current ratio: 1.83193568980371
Quick ratio: 1.83193568980371
Interest coverage ratio: -0.44473024666930483
COGS to revenue (%): 32.75866033284741
R&D to revenue (%): 26.21621745908386
SG&A to revenue (%): 44.125965133336706
Free cash flow (dilution-adjusted): 9123000
Retained earnings: 259963000
Receivables turnover: 1.2647702025195715
Capitalized R&D asset: 108311700
ROCI (R&D-adjusted, %): -0.08986545593693936
Rosenberg metric: 0.22566023240180544
FCF margin (%): 4.195312176660213
Revenue growth (%): 6.0196967480863925
Rule of 40 score: 10.215008924746606
Financial ratios for FJET — annual report dated 2023-12-31
Total revenue: 0
Operating income: -4085158
Net income: -4681583
Capital expenditures: 0
Operating cash flow: -3362780
Depreciation & amortization: 78906
Net tangible assets: -7936288
Owner earnings: -4602677
Buffett classification: The Gruesome
Shares outstanding: 49626351
Book value: -7936288
Debt to equity: -1.0354117693309517
Current ratio: 0.7591187167201414
Quick ratio: 0.7591187167201414
Interest coverage ratio: -4.423392724693704
Free cash flow (dilution-adjusted): -3362780
Retained earnings: -8978038
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -503.49015489888683
Rule of 40 score: 0
Financial ratios for FJET — quarterly report dated 2024-12-31
Total revenue: 0
Operating income: -1159251
Net income: -642527
Capital expenditures: 0
Operating cash flow: -1860095
Depreciation & amortization: 26238
Net tangible assets: -5890456
Owner earnings: -616289
Buffett classification: The Gruesome
Shares outstanding: 49626351
Book value: -5890456
Debt to equity: -1.7935927201561306
Current ratio: 0.5210983391740365
Quick ratio: 0.5210983391740365
Interest coverage ratio: -1.8183473718883818
Free cash flow (dilution-adjusted): -1860095
Retained earnings: -16886815
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FJET — annual report dated 2024-12-31
Total revenue: 0
Operating income: -4003183
Net income: -7908777
Capital expenditures: 0
Operating cash flow: -3864714
Depreciation & amortization: 92702
Net tangible assets: -5890456
Owner earnings: -7816075
Buffett classification: The Gruesome
Shares outstanding: 49626351
Book value: -5890456
Debt to equity: -1.7935927201561306
Current ratio: 0.5210983391740365
Quick ratio: 0.5210983391740365
Interest coverage ratio: -1.763686893140792
Free cash flow (dilution-adjusted): -3864714
Retained earnings: -16886815
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for FJET — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -1832477
Net income: -2653107
Capital expenditures: 0
Operating cash flow: -1669732
Depreciation & amortization: 26268
Owner earnings: -2626839
Buffett classification: The Gruesome
Shares outstanding: 49626351
Interest coverage ratio: -7.651133175228806
Free cash flow (dilution-adjusted): -1669732
Capitalized R&D asset: 255479
ROCI (R&D-adjusted, %): -650.6044201937016
Rule of 40 score: 0
Financial ratios for FJET — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -1921305
Net income: -2049910
Capital expenditures: 0
Depreciation & amortization: 5080
Net tangible assets: -5495295
Owner earnings: -2044830
Buffett classification: The Gruesome
Shares outstanding: 49626351
Book value: -5495295
Debt to equity: -2.0517107816777806
Current ratio: 0.25233196963094334
Quick ratio: 0.25233196963094334
Interest coverage ratio: -6.730369078145361
Retained earnings: -23148134
Receivables turnover: 0
Capitalized R&D asset: 278521.07
Rule of 40 score: 0
Financial ratios for HIVE.V — annual report dated 2022-03-31
Total revenue: 168947223.2
Gross profit: 77528877.6
Operating income: 63424615.2
Net income: 63697703.2
Capital expenditures: 167890864
Operating cash flow: 53023432
Depreciation & amortization: 53617377.6
Net tangible assets: 310973576.8
Owner earnings: -50575783.19999999
Return on net tangible assets (%): -16.263691507310078
Capex to operating income (%): 264.70931431051076
Buffett classification: The Gruesome
Shares outstanding: 253256770
Book value: 311242052
Debt to equity: 0.12415324391962304
Current ratio: 7.611580732621281
Quick ratio: 1.1117602801675823
Effective tax rate (%): 2.9449720873083294
Interest coverage ratio: 20.4853939627587
COGS to revenue (%): 54.11059375138638
SG&A to revenue (%): 8.384246234832466
Free cash flow (dilution-adjusted): -122653116.8
Retained earnings: -48194844.8
Inventory turnover: 0.6721920885697618
Receivables turnover: 31.24940777745898
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.605281376583346
FCF margin (%): -72.598480446644
Rule of 40 score: -72.598480446644
Financial ratios for HIVE.V — annual report dated 2023-03-31
Total revenue: 78754074.07407407
Gross profit: -22870370.37037037
Operating income: -38885925.925925925
Net income: -175128148.14814815
Capital expenditures: 30286666.666666664
Operating cash flow: 33171851.85185185
Depreciation & amortization: 60540740.74074074
Net tangible assets: 110183703.7037037
Owner earnings: -144874074.07407406
Return on net tangible assets (%): -131.48412079490143
Buffett classification: The Gruesome
Shares outstanding: 253256770
Book value: 110233333.33333334
Debt to equity: 0.24121224338944322
Current ratio: 3.5760360672793476
Quick ratio: 0.7193081324778915
Interest coverage ratio: -13.24987380111055
COGS to revenue (%): 129.04023777723432
SG&A to revenue (%): 20.336161327338736
Free cash flow (dilution-adjusted): -4759259.259259259
Retained earnings: -219752592.59259257
Inventory turnover: 2.0818677066419826
Receivables turnover: 11.366046611075477
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.335916416737458
FCF margin (%): -6.04319118117346
Revenue growth (%): -53.38539895334955
Rule of 40 score: -59.42859013452301
Financial ratios for HIVE.V — annual report dated 2024-03-31
Total revenue: 84788888.88888888
Gross profit: -19316296.296296295
Operating income: -39486666.666666664
Net income: 19629629.629629627
Capital expenditures: 56557777.777777776
Operating cash flow: 7140740.740740741
Depreciation & amortization: 47110370.370370366
Net tangible assets: 192157037.03703701
Owner earnings: 10182222.222222216
Return on net tangible assets (%): 5.298906758361214
Buffett classification: The Gruesome
Shares outstanding: 253256770
Book value: 192157037.03703704
Debt to equity: 0.11607789924907096
Current ratio: 6.828356558283566
Quick ratio: 0.8693135736931363
Effective tax rate (%): 18.92305338840447
Interest coverage ratio: -17.62797619047619
COGS to revenue (%): 122.78163630804177
SG&A to revenue (%): 17.86834403529463
Free cash flow (dilution-adjusted): -56180740.74074073
Retained earnings: -200641481.48148146
Inventory turnover: 0.8694484827863528
Receivables turnover: 16.51969981238274
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.068451401508106
FCF margin (%): -66.25955532258769
Revenue growth (%): 7.662860475178228
Rule of 40 score: -58.59669484740946
Financial ratios for HIVE.V — quarterly report dated 2024-12-31
Total revenue: 20439860.139860142
Gross profit: -8932167.832167832
Operating income: -14589510.48951049
Net income: 47664335.66433567
Capital expenditures: 38671328.67132867
Operating cash flow: -19904895.104895107
Depreciation & amortization: 12622377.622377623
Net tangible assets: 303748251.74825174
Owner earnings: 21615384.615384616
Return on net tangible assets (%): 7.116216962887928
Buffett classification: The Gruesome
Shares outstanding: 253256770
Book value: 303748251.74825174
Debt to equity: 0.05803250759738466
Current ratio: 10.40934711131987
Quick ratio: 1.6592296852982626
Effective tax rate (%): 0.18013268309828218
Interest coverage ratio: -49.79236276849642
COGS to revenue (%): 143.6997502480413
SG&A to revenue (%): 27.677991036299566
Free cash flow (dilution-adjusted): -65883916.08391608
Retained earnings: -245460839.16083917
Inventory turnover: 0.16104690843002079
Receivables turnover: 3.2804713804713805
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.648815346460745
FCF margin (%): -322.33056211297
Rule of 40 score: -322.33056211297
Financial ratios for HIVE.V — quarterly report dated 2025-03-31
Total revenue: 21790909.090909094
Gross profit: -6469230.76923077
Operating income: -13391608.391608393
Net income: 99300.6993006993
Capital expenditures: 47000699.3006993
Operating cash flow: 28132867.132867135
Depreciation & amortization: 11009090.90909091
Net tangible assets: 314081818.1818182
Owner earnings: -35892307.692307696
Return on net tangible assets (%): -11.427693554527906
Buffett classification: The Gruesome
Shares outstanding: 253256770
Book value: 314081818.1818182
Debt to equity: 0.1228155328997611
Current ratio: 3.6647361159543337
Quick ratio: 0.9183104143608714
Effective tax rate (%): 95.69827325053014
Interest coverage ratio: -72.26415094339623
COGS to revenue (%): 129.68775071403357
SG&A to revenue (%): 31.76727319405667
Free cash flow (dilution-adjusted): -23888111.88811189
Retained earnings: -191511888.1118881
Inventory turnover: 0.22309076656398705
Receivables turnover: 2.6501956114985545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -4.112610358623918
FCF margin (%): -109.6242097493662
Revenue growth (%): 6.609873755516784
Rule of 40 score: -103.01433599384941
Financial ratios for HIVE.V — annual report dated 2025-03-31
Total revenue: 80614685.31468531
Gross profit: -27511888.111888114
Operating income: -46092307.692307696
Net income: -2095104.895104895
Capital expenditures: 108474125.87412588
Operating cash flow: 11632167.832167832
Depreciation & amortization: 45097902.0979021
Net tangible assets: 314081818.1818182
Owner earnings: -65471328.67132868
Return on net tangible assets (%): -20.845310005633028
Buffett classification: The Gruesome
Shares outstanding: 253256770
Book value: 314081818.1818182
Debt to equity: 0.1228155328997611
Current ratio: 3.6647361159543337
Quick ratio: 0.9183104143608714
Effective tax rate (%): 285.85607940446647
Interest coverage ratio: -28.782532751091704
COGS to revenue (%): 134.12763816480017
SG&A to revenue (%): 23.886397349040152
Free cash flow (dilution-adjusted): -117873426.57342659
Retained earnings: -191511888.1118881
Inventory turnover: 0.8535711525509809
Receivables turnover: 9.804303452968192
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -14.155110911625052
FCF margin (%): -146.21830515531886
Revenue growth (%): -4.923054929607142
Rule of 40 score: -151.141360084926
Financial ratios for HIVE.V — quarterly report dated 2025-06-30
Total revenue: 33292700.729927003
Gross profit: -4519708.02919708
Operating income: 4989781.02189781
Net income: 25559124.08759124
Capital expenditures: 33490510.948905107
Operating cash flow: 7465693.430656934
Depreciation & amortization: 16066423.357664233
Net tangible assets: 409139416.05839413
Owner earnings: 8135036.496350367
Return on net tangible assets (%): 1.9883287156056602
Capex to operating income (%): 671.1819777647747
Buffett classification: The Gruesome
Shares outstanding: 253256770
Book value: 409139416.05839413
Debt to equity: 0.07176359137302617
Current ratio: 3.420521462518698
Quick ratio: 2.5244163368867514
Effective tax rate (%): 1.819711201458012
Interest coverage ratio: 23.73611111111111
COGS to revenue (%): 113.57567253513407
SG&A to revenue (%): 25.213216110148867
Free cash flow (dilution-adjusted): -31298540.145985402
Retained earnings: -174340145.98540145
Inventory turnover: 1.0945991632506444
Receivables turnover: 1.321292004634994
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.1869683515621066
FCF margin (%): -94.01021683365856
Revenue growth (%): 52.78252316612306
Rule of 40 score: -41.2276936675355
Financial ratios for HIVE.V — quarterly report dated 2025-09-30
Total revenue: 62771942.44604317
Gross profit: 2958273.3812949643
Operating income: -6589928.057553957
Net income: -11364748.20143885
Capital expenditures: 26995683.45323741
Operating cash flow: -7634532.37410072
Depreciation & amortization: 27548201.438848924
Net tangible assets: 449351798.5611511
Owner earnings: -10812230.215827337
Return on net tangible assets (%): -2.4061838075309114
Buffett classification: The Gruesome
Shares outstanding: 253256770
Book value: 449351798.56115115
Debt to equity: 0.037063780121325836
Current ratio: 2.549222218077368
Quick ratio: 2.094788674599918
Interest coverage ratio: -27.926829268292682
COGS to revenue (%): 95.28726805955095
SG&A to revenue (%): 15.210938305846216
Free cash flow (dilution-adjusted): -38608633.093525186
Retained earnings: -183196402.87769786
Inventory turnover: 3.4124527992119518
Receivables turnover: 5.13434153230552
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4326894051367234
FCF margin (%): -61.50619462941103
Revenue growth (%): 88.54566036938273
Rule of 40 score: 27.039465739971703
Financial ratios for HIVE.V — quarterly report dated 2025-12-31
Total revenue: 67964233.57664233
Gross profit: -18449635.03649635
Operating income: -28593430.656934306
Net income: -66662043.795620434
Capital expenditures: 40078832.11678832
Operating cash flow: 33565693.43065693
Depreciation & amortization: 41912408.759124085
Net tangible assets: 408226277.3722627
Owner earnings: -64828467.15328467
Return on net tangible assets (%): -15.88052282439609
Buffett classification: The Gruesome
Shares outstanding: 253256770
Book value: 408226277.3722628
Debt to equity: 0.03232606790995404
Current ratio: 1.7376503662338159
Quick ratio: 0.9324905811929852
Interest coverage ratio: -131.0133779264214
COGS to revenue (%): 127.1460944464134
SG&A to revenue (%): 16.587728624974492
Free cash flow (dilution-adjusted): -11675912.408759125
Retained earnings: -252532846.71532845
Inventory turnover: 2.8119759625662097
Receivables turnover: 6.303208773354997
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.851948379061966
FCF margin (%): -17.17949544092535
Revenue growth (%): 8.271675096022872
Rule of 40 score: -8.907820344902479
Financial ratios for IEAG — quarterly report dated 2025-08-31
Capital expenditures: 0
Net tangible assets: 20000
Buffett classification: The Gruesome
Shares outstanding: 34895000
Book value: 20000
Debt to equity: 0
Quick ratio: 0
Retained earnings: -5000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEAG — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: -14818
Buffett classification: The Gruesome
Shares outstanding: 34895000
Book value: -14818
Debt to equity: 0
Quick ratio: 0
Retained earnings: -39818
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IEAG — annual report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: -35111
Buffett classification: The Gruesome
Shares outstanding: 34895000
Book value: -35111
Debt to equity: -2.9976360684685712
Current ratio: 0.015955730400335044
Quick ratio: 0.015955730400335044
Retained earnings: -60111
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for IPST — annual report dated 2022-12-31
Total revenue: 8309566
Gross profit: 2212426
Operating income: -11771574
Net income: -12268216
Capital expenditures: 639383
Operating cash flow: -9296606
Depreciation & amortization: 1889830
Net tangible assets: -6631291
Owner earnings: -11017769
Buffett classification: The Gruesome
Shares outstanding: 721578
Book value: -6631291
Debt to equity: -4.020884168708627
Current ratio: 0.24936110499458297
Quick ratio: 0.08270958474295664
Interest coverage ratio: -4.507813711648019
COGS to revenue (%): 73.37495123090665
SG&A to revenue (%): 153.29320448264085
Free cash flow (dilution-adjusted): -10022648
Retained earnings: -38046057
Inventory turnover: 1.6741668829002483
Receivables turnover: 16.796706784121735
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -192.79485848669557
FCF margin (%): -120.61578185912478
Rule of 40 score: -120.61578185912478
Financial ratios for IPST — annual report dated 2023-12-31
Total revenue: 7971224
Gross profit: 2151041
Operating income: -11100959
Net income: -36798419
Capital expenditures: 26512
Operating cash flow: -8479746
Depreciation & amortization: 1923046
Net tangible assets: -43422456
Owner earnings: -34901885
Buffett classification: The Gruesome
Shares outstanding: 721578
Book value: -43422456
Debt to equity: -1.2984995367373968
Current ratio: 0.08389695993749555
Quick ratio: 0.04004000595589639
Interest coverage ratio: -4.393391880446742
COGS to revenue (%): 73.0149221750637
SG&A to revenue (%): 151.69564925035354
Free cash flow (dilution-adjusted): -8524852
Retained earnings: -74844476
Inventory turnover: 2.1115544107243274
Receivables turnover: 11.04151637550351
Capitalized R&D asset: 0
FCF margin (%): -106.94533236050073
Revenue growth (%): -4.071716862228424
Rule of 40 score: -111.01704922272916
Financial ratios for RRKABEL.NS — annual report dated 2023-03-31
Total revenue: 674408014.6163216
Gross profit: 116098514.00730817
Operating income: 32703386.11449452
Net income: 23126991.473812424
Capital expenditures: 13132338.611449452
Operating cash flow: 55267831.91230208
Depreciation & amortization: 7262874.543239952
Net tangible assets: 172131973.20341048
Owner earnings: 17257527.405602925
Return on net tangible assets (%): 10.025753545048538
Capex to operating income (%): 40.155898736213885
Buffett classification: The Good
Shares outstanding: 113105505
Book value: 172922009.7442144
Debt to equity: 0.4088501874740656
Current ratio: 1.769877529134417
Quick ratio: 0.9875984902541507
Effective tax rate (%): 25.828552901170543
Interest coverage ratio: 6.641554425933484
COGS to revenue (%): 82.78512243462025
R&D to revenue (%): 0.03896953123394293
SG&A to revenue (%): 4.66243521769207
Free cash flow (dilution-adjusted): 42009220.46285019
Retained earnings: 107633373.93422656
Inventory turnover: 5.32882316635299
Receivables turnover: 9.354932387853045
Capitalized R&D asset: 632669.8993180303
ROCI (R&D-adjusted, %): 17.43870115178831
FCF margin (%): 6.229051190435468
Rule of 40 score: 6.229051190435468
Financial ratios for RYDE — annual report dated 2022-12-31
Total revenue: 6585820.895522388
Gross profit: -563432.8358208955
Operating income: -3553731.343283582
Net income: -3673880.597014925
Capital expenditures: 11194.029850746268
Operating cash flow: -2866417.910447761
Depreciation & amortization: 224626.86567164178
Net tangible assets: -4099999.9999999995
Owner earnings: -3460447.7611940294
Buffett classification: The Gruesome
Shares outstanding: 150049131
Book value: -3730597.014925373
Debt to equity: -1.019003800760152
Current ratio: 0.8909649952696309
Quick ratio: 0.8909649952696309
Interest coverage ratio: -24.050505050505052
COGS to revenue (%): 108.55524079320114
SG&A to revenue (%): 30.59490084985836
Free cash flow (dilution-adjusted): -3226119.4029850746
Retained earnings: -9750746.268656716
Receivables turnover: 37.71367521367522
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5012.631578947372
FCF margin (%): -48.98583569405099
Rule of 40 score: -48.98583569405099
Financial ratios for RYDE — annual report dated 2023-12-31
Total revenue: 6565909.090909091
Gross profit: -150000
Operating income: -8908333.333333332
Net income: -9717424.242424242
Capital expenditures: 2272.7272727272725
Operating cash flow: -1221212.121212121
Depreciation & amortization: 304545.45454545453
Net tangible assets: -6072727.2727272725
Owner earnings: -9415151.515151514
Buffett classification: The Gruesome
Shares outstanding: 150049131
Book value: -5622727.2727272725
Debt to equity: -0.7008892481810833
Current ratio: 0.35457217764360055
Quick ratio: 0.35457217764360055
Interest coverage ratio: -26.365470852017935
COGS to revenue (%): 102.28452751817238
SG&A to revenue (%): 114.4455982462213
Free cash flow (dilution-adjusted): -6860606.06060606
Retained earnings: -19615909.09090909
Receivables turnover: 42.69458128078818
Capitalized R&D asset: 0
FCF margin (%): -104.48828891196491
Revenue growth (%): -0.3023435488024681
Rule of 40 score: -104.79063246076738
Financial ratios for YXT — annual report dated 2022-12-31
Total revenue: 61872988.505747125
Gross profit: 33439224.137931034
Operating income: -89200000
Net income: -88329741.37931034
Capital expenditures: 1710775.8620689656
Operating cash flow: -65637212.64367816
Depreciation & amortization: 4520258.620689656
Net tangible assets: -498700574.7126437
Owner earnings: -85520258.62068965
Buffett classification: The Gruesome
Shares outstanding: 5395872
Book value: -460804454.02298856
Debt to equity: -0.022335689179249555
Current ratio: 0.9984479305740986
Quick ratio: 0.9984479305740986
Interest coverage ratio: -1249.158953722334
COGS to revenue (%): 45.955052526960124
R&D to revenue (%): 72.47257544654883
SG&A to revenue (%): 127.94633983224813
Free cash flow (dilution-adjusted): -78640229.88505748
Retained earnings: -469408620.6896552
Receivables turnover: 9.673517981894557
Capitalized R&D asset: 44840948.27586207
ROCI (R&D-adjusted, %): -55.073302983887764
FCF margin (%): -127.09945290221907
Rule of 40 score: -127.09945290221907
Financial ratios for YXT — annual report dated 2023-12-31
Total revenue: 59636568.2137834
Gross profit: 32284388.185654007
Operating income: -46216174.40225035
Net income: -31006329.11392405
Capital expenditures: 651054.852320675
Operating cash flow: -36150351.61744022
Depreciation & amortization: 4409704.641350211
Net tangible assets: -509523628.6919831
Owner earnings: -27247679.324894514
Buffett classification: The Gruesome
Shares outstanding: 5395872
Book value: -479745850.9142053
Debt to equity: -0.08850062137330683
Current ratio: 0.8934189121614352
Quick ratio: 0.8934189121614352
Interest coverage ratio: -70.66602150537635
COGS to revenue (%): 45.8647786875967
R&D to revenue (%): 41.634513791932385
SG&A to revenue (%): 91.32461982566696
Free cash flow (dilution-adjusted): -40616455.69620253
Retained earnings: -490953727.14486635
Receivables turnover: 12.658705517076665
Capitalized R&D asset: 54872830.5628304
ROCI (R&D-adjusted, %): -37.712552148182446
Rosenberg metric: -0.02575404840175239
FCF margin (%): -68.10662805177164
Revenue growth (%): -3.614534138359899
Rule of 40 score: -71.72116219013154
Financial ratios for 1628.HK — quarterly report dated 2025-12-31
Capital expenditures: 0
Net tangible assets: 1730722622.107969
Buffett classification: The Gruesome
Stock price: 0.012853470437017995
Trailing EPS: 27.95
P/E ratio: 0.00045987371867685134
Shares outstanding: 1486954545
Book value: 1292651799.4858618
P/B ratio: 0.014785517873373823
Market cap (USD): 22552779.4344473
Yahoo trailing P/E: 0.00
Yahoo forward P/E: -0.24
EV/EBITDA: -4.00
Debt to equity: 3.2939
Current ratio: 1.89
Quick ratio: 0.79
Buyback yield (%): 0
Retained earnings: 1295421722.3650386
Capitalized R&D asset: 0
Rule of 40 score: 0